Skip to main content

Inmune Bio, Inc.

INMB
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001711754

No open-market purchases or sales by Inmune Bio, Inc. insiders were filed in the last 90 days; 82 institutions reported holding it in 13F filings for Q2 2026, worth $7.08M in total; no superinvestor holds it.

13F holders, Q3 2021

Institutional positions in Inmune Bio, Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
41
0 vs. Q2 2021
Shares held
1.94M
+205.1K (+11.8%) vs. Q2 2021
Total value
$37.7M
+$7.09M (+23.1%) vs. Q2 2021
New holders
9
17 more added
Sold out
9
7 more reduced

Compare with Q2 2021: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting INMB on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2021: 41 institutions
Q1 2021: 33 institutionsQ2 2021: 41 institutionsQ3 2021: 41 institutionsQ4 2021: 43 institutionsQ1 2022: 34 institutionsQ2 2022: 36 institutionsQ3 2022: 33 institutionsQ4 2022: 34 institutionsQ1 2023: 35 institutionsQ2 2023: 34 institutionsQ3 2023: 37 institutionsQ4 2023: 48 institutionsQ1 2024: 52 institutionsQ2 2024: 57 institutionsQ3 2024: 67 institutionsQ4 2024: 73 institutionsQ1 2025: 82 institutionsQ2 2025: 79 institutionsQ3 2025: 73 institutionsQ4 2025: 74 institutionsQ1 2026: 82 institutionsQ2 2026: 82 institutions
Value heldQ3 2021: $37.7M
Q1 2021: $15.5MQ2 2021: $30.6MQ3 2021: $37.7MQ4 2021: $25.4MQ1 2022: $19.3MQ2 2022: $17.7MQ3 2022: $11.9MQ4 2022: $10.4MQ1 2023: $11.7MQ2 2023: $18.2MQ3 2023: $14.5MQ4 2023: $25.8MQ1 2024: $32.2MQ2 2024: $40.3MQ3 2024: $28.8MQ4 2024: $29.5MQ1 2025: $48.1MQ2 2025: $12.7MQ3 2025: $9.64MQ4 2025: $7.93MQ1 2026: $6.09MQ2 2026: $7.08M
Institutions holding INMB and their total value by quarter
QuarterHoldersValue
Q2 202682$7.08M
Q1 202682$6.09M
Q4 202574$7.93M
Q3 202573$9.64M
Q2 202579$12.7M
Q1 202582$48.1M
Q4 202473$29.5M
Q3 202467$28.8M
Q2 202457$40.3M
Q1 202452$32.2M
Q4 202348$25.8M
Q3 202337$14.5M
Q2 202334$18.2M
Q1 202335$11.7M
Q4 202234$10.4M
Q3 202233$11.9M
Q2 202236$17.7M
Q1 202234$19.3M
Q4 202143$25.4M
Q3 202141$37.7M
Q2 202141$30.6M
Q1 202133$15.5M

Institutions, Q3 2021

Shares, value and share of portfolio for each institution holding Inmune Bio, Inc.; share changes are against Q2 2021.

Institutions holding INMB in Q3 2021
InstitutionSharesValue% of portfolioChange in sharesAction
Vanguard Group Inc448,911$8.72M0.00%+69,743+18.4%Added
ACT Capital Management, LLC275,000$5.34M2.77%+275,000New
BlackRock Inc.146,429$2.84M0.00%−37,577−20.4%Reduced
Royal Bank of Canada126,411$2.46M0.00%+59,953+90.2%Added
Millennium Management LLC123,511$2.40M0.00%+123,511New
Deutsche Bank AG106,056$2.06M0.00%+80.0%Added
Janney Montgomery Scott LLC99,323$1.93M0.01%+41,983+73.2%Added
Geode Capital Management, LLC89,607$1.74M0.00%+15,813+21.4%Added
Susquehanna International Group, LLP82,529$1.60M0.00%+6,815+9.0%Added
Marshall Wace, LLP64,650$1.26M0.01%+64,650New
Citadel Advisors LLC52,692$1.02M0.00%−3,364−6.0%Reduced
UBS Group AG30,126$585.0K0.00%+22,680+304.6%Added
State Street Corp27,716$538.0K0.00%−7,100−20.4%Reduced
Ikarian Capital, LLC26,632$517.0K0.12%−120,251−81.9%Reduced
Morgan Stanley24,631$478.0K0.00%+13,088+113.4%Added
Northern Trust Corp22,221$432.0K0.00%+8,272+59.3%Added
Alps Advisors Inc21,699$421.0K0.00%+2,036+10.4%Added
DG Capital Management, LLC20,000$388.0K0.08%+20,000New
Cubist Systematic Strategies, LLC19,989$388.0K0.00%+19,989New
Group One Trading, L.P.17,806$346.0K0.01%+13,130+280.8%Added
Susquehanna Fundamental Investments, LLC17,200$334.0K0.01%+17,200New
Financial Advocates Investment Management16,667$324.0K0.02%−3,000−15.3%Reduced
Belvedere Trading LLC16,177$302.0K0.08%−11,791−42.2%Reduced
Fermata Advisors, LLC12,830$249.0K0.11%+1,080+9.2%Added
Advisor Group Holdings, Inc.12,170$237.0K0.00%−15,092−55.4%Reduced
Dimensional Fund Advisors LP11,052$215.0K0.00%00.0%Unchanged
YorkBridge Wealth Partners, LLC10,369$201.0K0.05%00.0%Unchanged
Simplex Trading, LLC7,366$135.0K0.00%+600+8.9%Added
Wells Fargo & Company2,627$51.0K0.00%+2,575+4,951.9%Added
Kelly Financial Services LLC2,000$38.8K0.02%+2,000New
Bank of America Corp1,799$35.0K0.00%+99+5.8%Added
Migdal Insurance & Financial Holdings Ltd.1,608$31.0K0.00%+1,608New
Leonteq Securities AG1,300$25.2K0.00%+1,300New
Valley National Advisers Inc1,000$19.0K0.00%00.0%Unchanged
Covington Capital Management1,000$19.0K0.00%00.0%Unchanged
Asset Dedication, LLC814$16.0K0.00%00.0%Unchanged
FNY Investment Advisers, LLC800$15.0K0.01%+500+166.7%Added
Captrust Financial Advisors400$8.00K0.00%00.0%Unchanged
Federation des caisses Desjardins du Quebec400$7.77K0.00%00.0%Unchanged
IFP Advisors, Inc284$6.00K0.00%+100+54.3%Added
Parallel Advisors, LLC100$2.00K0.00%00.0%Unchanged
EAM Investors, LLC0$00.00%−161,793−100.0%Sold out
EAM Global Investors LLC0$00.00%−116,809−100.0%Sold out
Altium Capital Management LP0$00.00%−52,257−100.0%Sold out
Boothbay Fund Management, LLC0$00.00%−24,158−100.0%Sold out
Virtu Financial LLC0$00.00%−10,530−100.0%Sold out
Marino, Stram & Associates LLC0$00.00%−10,369−100.0%Sold out
Advisory Services Network, LLC0$00.00%−3,108−100.0%Sold out
Tower Research Capital LLC (TRC)0$00.00%−1,401−100.0%Sold out
FFT Wealth Management LLC0$00.00%−25−100.0%Sold out